← Back to news
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Published: February 24, 2026 · GlobeNewswire

View original

WALTHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), today announced its fourth quarter and full year 2025 financial results and business highlights.